216 related articles for article (PubMed ID: 26746146)
1. Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration.
Losina E; Michl G; Collins JE; Hunter DJ; Jordan JM; Yelin E; Paltiel AD; Katz JN
Osteoarthritis Cartilage; 2016 May; 24(5):776-85. PubMed ID: 26746146
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.
Katz JN; Smith SR; Collins JE; Solomon DH; Jordan JM; Hunter DJ; Suter LG; Yelin E; Paltiel AD; Losina E
Osteoarthritis Cartilage; 2016 Mar; 24(3):409-18. PubMed ID: 26525846
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
Losina E; Daigle ME; Suter LG; Hunter DJ; Solomon DH; Walensky RP; Jordan JM; Burbine SA; Paltiel AD; Katz JN
Osteoarthritis Cartilage; 2013 May; 21(5):655-67. PubMed ID: 23380251
[TBL] [Abstract][Full Text] [Related]
4. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
Hochberg MC; Carrino JA; Schnitzer TJ; Guermazi A; Walsh DA; White A; Nakajo S; Fountaine RJ; Hickman A; Pixton G; Viktrup L; Brown MT; West CR; Verburg KM
Arthritis Rheumatol; 2021 Jul; 73(7):1167-1177. PubMed ID: 33538113
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of duloxetine for knee OA subjects: the role of pain severity.
Sullivan JK; Huizinga J; Edwards RR; Hunter DJ; Neogi T; Yelin E; Katz JN; Losina E
Osteoarthritis Cartilage; 2021 Jan; 29(1):28-38. PubMed ID: 33171315
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
Berenbaum F; Blanco FJ; Guermazi A; Miki K; Yamabe T; Viktrup L; Junor R; Carey W; Brown MT; West CR; Verburg KM
Ann Rheum Dis; 2020 Jun; 79(6):800-810. PubMed ID: 32234715
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?
Losina E; Burbine SA; Suter LG; Hunter DJ; Solomon DH; Daigle ME; Dervan EE; Jordan JM; Katz JN
Osteoarthritis Cartilage; 2014 Mar; 22(3):415-30. PubMed ID: 24487044
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation.
Losina E; Usiskin IM; Smith SR; Sullivan JK; Smith KC; Hunter DJ; Messier SP; Paltiel AD; Katz JN
Osteoarthritis Cartilage; 2018 May; 26(5):641-650. PubMed ID: 29481917
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis.
Losina E; Smith KC; Paltiel AD; Collins JE; Suter LG; Hunter DJ; Katz JN; Messier SP
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):855-864. PubMed ID: 30055077
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of total knee replacement in addition to non-surgical treatment: a 2-year outcome from a randomised trial in secondary care in Denmark.
Skou ST; Roos E; Laursen M; Arendt-Nielsen L; Rasmussen S; Simonsen O; Ibsen R; Larsen AT; Kjellberg J
BMJ Open; 2020 Jan; 10(1):e033495. PubMed ID: 31948990
[TBL] [Abstract][Full Text] [Related]
13. Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study.
Neogi T; Hunter DJ; Churchill M; Shirinsky I; White A; Guermazi A; Omata M; Fountaine RJ; Pixton G; Viktrup L; Brown MT; West CR; Verburg KM
Arthritis Res Ther; 2022 Mar; 24(1):78. PubMed ID: 35351194
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Treating Early to Moderate Stage Knee Osteoarthritis with Intra-articular Hyaluronic Acid Compared to Conservative Interventions.
Rosen J; Niazi F; Dysart S
Adv Ther; 2020 Jan; 37(1):344-352. PubMed ID: 31735982
[TBL] [Abstract][Full Text] [Related]
16. The Value of Total Knee Replacement in Patients With Knee Osteoarthritis and a Body Mass Index of 40 kg/m
Chen AT; Bronsther CI; Stanley EE; Paltiel AD; Sullivan JK; Collins JE; Neogi T; Katz JN; Losina E
Ann Intern Med; 2021 Jun; 174(6):747-757. PubMed ID: 33750190
[TBL] [Abstract][Full Text] [Related]
17. Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study.
Schnitzer TJ; Khan A; Bessette L; Davignon I; Brown MT; Pixton G; Prucka WR; Tive L; Viktrup L; West CR
Semin Arthritis Rheum; 2020 Jun; 50(3):387-393. PubMed ID: 32252976
[TBL] [Abstract][Full Text] [Related]
18. Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study.
Nagashima H; Suzuki M; Araki S; Yamabe T; Muto C;
Osteoarthritis Cartilage; 2011 Dec; 19(12):1405-12. PubMed ID: 22004765
[TBL] [Abstract][Full Text] [Related]
19. Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee Osteoarthritis Patients With Moderate Pain? A Cost-Effectiveness Analysis.
Lenhard NK; Sullivan JK; Ross EL; Song S; Edwards RR; Hunter DJ; Neogi T; Katz JN; Losina E
Arthritis Care Res (Hoboken); 2022 May; 74(5):776-789. PubMed ID: 33253496
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis.
Smith SR; Katz JN; Collins JE; Solomon DH; Jordan JM; Suter LG; Yelin EH; David Paltiel A; Losina E
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):234-242. PubMed ID: 27111538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
